Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension. [electronic resource]
Producer: 20040122Description: 209-16 p. digitalISSN:- 0014-2999
- Albuminuria -- complications
- Animals
- Body Weight -- drug effects
- Desoxycorticosterone -- administration & dosage
- Disease Models, Animal
- Endothelin A Receptor Antagonists
- Endothelin-1 -- urine
- Hypertension -- drug therapy
- Kidney
- Kidney Diseases -- drug therapy
- Male
- Organ Size -- drug effects
- Osteopontin
- Phenylpropionates -- administration & dosage
- Pyrimidines -- administration & dosage
- RNA, Messenger -- biosynthesis
- Rats
- Rats, Inbred Strains -- genetics
- Receptor, Endothelin A -- drug effects
- Receptor, Endothelin B -- drug effects
- Sialoglycoproteins -- biosynthesis
- Sodium -- urine
- Sodium Chloride, Dietary -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.